Master di II livello in Farmaci Oncologici e Radioterapia: Biologia e Clinica (V edition, 2025/26–2026/27)

Università degli Studi di Brescia – SMAE / ASST Spedali Civili di Brescia

Radiation OncologyRadiation oncologyPostgraduate degree programme
Destination
ITA
Brescia, Lombardy, Italy

Overview

Biennial master enriching the training of radiation oncologists in tumour biology, radiobiology and clinical pharmacology, with clinical training in the radiotherapy units of Spedali Civili Brescia, Ospedale Maggiore Novara and Sacro Cuore Don Calabria (Negrar).

The programme

Focus
Radiation oncology / oncological pharmacology
Training type
Postgraduate degree programme
Duration
2 years (April 2026 – November 2027; 1,525 hours, 61 CFU)
Start
April 2026 (current edition)
Positions
4–20
Accreditation
Master universitario di II livello (60 CFU) under D.M. 270/2004.
Department
Not stated on official page

Eligibility and visa

Eligibility
Specialisation diploma in Radiotherapy.
International applicants
Foreign titles accepted if declared equivalent, or recognised by the master board for enrolment purposes (translated, legalised degree with Dichiarazione di valore).
Visa support
Not stated on official page
Licence requirement
Not stated on official page

How to apply

Deadline
30 March 2026 (closed)
Application method
Online application on the UniBs portal.

Funding

Funding
Fee €1,316.

Official sources

Similar programmes